Field Randomization of Nerinetide (NA-1) Therapy in Early Responders

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of this study is to determine whether nerinetide (NA-1) is effective in reducing global disability in patients with acute cerebral ischemia if administered early after symptom onset.
Epistemonikos ID: e3e707299695fc54a88f61b6174f7309fb6acade
First added on: May 12, 2024